Financial Freedom LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
4,318
+230
+6% +$6.12K 0.06% 126
2025
Q4
$102K Buy
4,088
+34
+0.8% +$857 0.05% 137
2025
Q3
$103K Sell
4,054
-41
-1% -$1.01K 0.05% 135
2025
Q2
$99.3K Buy
4,095
+43
+1% +$1K 0.05% 134
2025
Q1
$103K Buy
4,052
+39
+1% +$1.02K 0.06% 131
2024
Q4
$106K Sell
4,013
-167
-4% -$4.53K 0.06% 126
2024
Q3
$121K Buy
4,180
+34
+0.8% +$992 0.06% 127
2024
Q2
$116K Sell
4,146
-1,661
-29% -$45.7K 0.07% 127
2024
Q1
$161K Buy
5,807
+35
+0.6% +$971 0.1% 109
2023
Q4
$166K Sell
5,772
-752
-12% -$22.7K 0.11% 102
2023
Q3
$216K Sell
6,524
-3
-0% -$106 0.15% 85
2023
Q2
$239K Buy
6,527
+28
+0.4% +$1.09K 0.17% 75
2023
Q1
$265K Buy
6,499
+203
+3% +$8.77K 0.19% 72
2022
Q4
$323K Buy
+6,296
New +$302K 0.22% 57

Other funds holding PFE

Financial Freedom LLC's PFE Position: Q1 2026 in Review

Financial Freedom LLC increased its Pfizer (PFE) stake by 5.6% in Q1 2026, buying an estimated $6.12K and bringing the position to 4,318 shares worth $121K. The position accounts for 0.06% of the portfolio, ranked #126.

Financial Freedom LLC first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $323K in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Financial Freedom LLC held 4,318 shares of Pfizer worth $121K as of Q1 2026.
  • Financial Freedom LLC bought 230 Pfizer shares in Q1 2026, an estimated $6.12K.
  • Pfizer made up 0.06% of Financial Freedom LLC's portfolio in Q1 2026, its #126 holding.
  • Financial Freedom LLC first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Financial Freedom LLC's Pfizer position peaked at $323K in Q4 2022.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.